We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Stem Cell May Help Repair Bone

By Biotechdaily staff writers
Posted on 25 Aug 2004
A single type of primitive stem cell, transplanted from donor mice, gave rise to both blood-forming and bone-forming cells in recipient mice, suggesting that it may someday be the basis of new medical treatments to replace or repair bone lost to disease or injury.

Researchers used a technique called retroviral insertion site analysis to determine which type of bone marrow cell from mice could give rise to bone-producing cells when transplanted into recipient mice. More...
In this technique, researchers add a piece of DNA marked with a green fluorescent protein to bone marrow cells taken from donor mice. The added DNA inserts itself randomly into one of the chromosomes and is duplicated each time the cell replicates. The daughter cells of the originally marked cell were identified by locating the marker in the same site of the chromosome in each succeeding generation.

Using this technique, the researchers at St. Jude Children's Research Hospital (Memphis, TN, USA) followed the fates of the cells removed from donor mice and transplanted into recipient mice whose own marrow cells had been destroyed by radiation. The cells identified in this study seem to be better able to engraft in bone than other bone marrow cells called mesenchymal cells. However, the osteoblasts that arose from donor cells were detectable for only several months in recipient mice, as occurs in human bone marrow transplant patients.

This suggests that repair and regeneration during the first few months after transplantation is driven by the transplanted donor cells that engraft in bones of the recipient. However, long-term maintenance of bone strength may be primarily controlled by other cells already present in the recipient's bone. The results of the research were reported in the August 10, 2004, issue of the Proceedings of the [U.S.] National Academy of Sciences.

"Our findings in mice coupled with previous experience with bone marrow transplantation in humans suggest that we have identified primitive cells in mice that are responsible for bone repair and regeneration,” said senior author Edwin Horwitz, M.D., Ph.D., associate member of the department of hematology/oncology at St. Jude.




Related Links:
St. Jude Med. Ctr

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.